Zeolites are effective ROS-scavengers in vitro

Biochemical and Biophysical Research Communications

Volumn 410, Issue 3, 2011, Pages 478-483

  Pellegrino, Perrine ^a   Mallet, Bernard ^a   Delliaux, Stéphane ^b   Jammes, Yves ^b   Guieu, Regis ^a,b   Schäf, Oliver ^b  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Fenton reaction; Ischemia modified albumin; ROS deactivation; Zeolites

Indexed keywords

CATION; FAUJASITE; FERRIERITE; FREE RADICAL; HYDROGEN; IRON; ISCHEMIA MODIFIED ALBUMIN; MORDENITE; PROTON; REACTIVE OXYGEN METABOLITE; SCAVENGER; SILICALITE 1; SODIUM; STILBITE; UNCLASSIFIED DRUG; WATER; ZEOLITE; ZEOLITE BETA;

ARTICLE; BLOOD SAMPLING; CHANNEL GATING; CONTROLLED STUDY; FENTON REACTION; HUMAN; IN VITRO STUDY; ION EXCHANGE; ION TRANSPORT; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE;

FREE RADICAL SCAVENGERS; HUMANS; ISCHEMIA; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN; ZEOLITES;

EID: 79960045862     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.002     Document Type: Article

References (22)

1. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2007, Oxford University Press, Oxford. fourth ed.
2. Delom F., Lejeune P.J., Vinet L., Carayon P., Mallet B. Involvement of oxidative reactions and extracellular protein chaperones in rescue of misassembled thyroglobulin in the follicular lumen. Biochem. Biophys. Res. Commun. 1999, 255:438-443.
3. Hultqvist M., Olosson L.A., Gelderman K.A., Holmdah R. The protective role of ROS in autoimmune disease. Trends Immunol. 2009, 30:201-208.
4. Zmijewski J.W., Lorne E., Tsuruta Y., Sha Y., Liu G., Abraham E. Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury. Am. J. Respir. Crit. Care Med. 2009, 179:694-704.
5. Gastaldello K., Husson C., Wens R., Vanherweghem J.L., Tielemans C. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. Nephrol. Dial. Transplant. 2000, 15:1638-1646.
6. Descamps-Latscha B., Witko-Sarsat V. Oxidative stress in chronic renal failure and hemodialysis. Nephrologie 2003, 24:377-379.
7. Foley R.N., Murray A.M., Li S., Herzog C.A., McBean A.M., Eggers P.W., Collins A.J. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J. Am. Soc. Nephrol. 2005, 16:489-495.
8. D.M. Ruthven, in: Robson, H. (Ed.), Verified Syntheses of Zeolitic Materials, second rev. ed., Elsevier, Amsterdam, London, New York, Oxford, Paris, Shannon, Tokyo, 2001.
9. Bergé-Lefranc D., Pizzala H., Paillaud J.L., Schäf O., Vagner C., Boulet P., Denoyel R. Adsorption studies of the uremic toxin para-cresol on MFI-type zeolites. Adsorption 2008, 14:377-387.
10. Bergé-Lefranc D., Pizzala H., Denoyel R., Hornebecq V., Bergé-Lefranc J.L., Guieu R., Brunet P., Ghobarkar H., Schäf O. Mechanism of creatinine adsorption from physiological solutions onto mordenite. Microporous Mesoporous Mater. 2009, 119:86-192.
11. Chan B., Dodsworth N., Woodrow J., Tucker A., Harris R. Site-specific N-terminal auto-degradation of human serum albumin. Eur. J. Biochem. 1995, 227:524-528.
12. Bar-Or D., Lau E., Winkler J.V. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia - a preliminary report. J. Emerg. Med. 2000, 19:311-315.
13. Wu A.H., Morris D.L., Fletcher D.R., Apple F.S., Christenson R.H., Painter P.C. Analysis of albumin cobalt binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc. Toxicol. 2001, 1:147-151.
14. Bar-Or D., Winkler J.V., Vanbenthuysen K., Harris L., Lau E., Hetzel F.W. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinas-MB, myoglobin, and troponin I. Am. Heart J. 2001, 141:985-991.
15. Pinnell A.E., Northam B.E. New automated dye-binding method for serum albumin determination with bromcresol purple. Clin. Chem. 1978, 24:80-86.
16. Ch. Baerlocher, L.B. McCusker, D.H. Olson, Atlas of Zeolite Framework Types, sixth revised ed. Published on behalf of Structure Commission of the International Zeolite Association. Elsevier, Amsterdam, Boston, Heidelberg, London, New York, Oxford, Paris, San Diego, San Francisco, Singapore, Sydney, Tokyo, 2007.
17. Weidenthaler C., Zibrowius B., Schimanke J., Mao Y., Mienert B., Bill E., Schmidt W. Oxidation behaviour of ferrous cation during ion exchange into zeolites under atmospheric conditions. Microporous Mesoporous Mater. 2005, 84:302-317.
18. Grotthuss T. Sur la decomposition de l'eau et des corps qu'elle contient en dissolution à l'aide de l'électricité galvanique. Ann. Chim. 1806, 58:54-73.
19. Coaccioli S., Standoli M.L., Biondi R., Panaccione A., Landucci P., Del Giorno R., Paladini A., Standoli M., Puxeddu A. Open comparison study of oxidative stress markers between patients with chronic renal failure in conservative therapy and patients in hemodialysis. Clin. Ther. 2010, 161:435-439.
20. Lim P.S., Chen W.C., Wu M.Y., Hu C.Y., Chien P.I. Increased oxidative stress in hemodialysis patients with high risk for sleep apnea syndrome. Blood Purif. 2009, 28:144-149.
21. Prabhu A., Sujatha D.I., Kanagarajan N., Vijayalakshmi M.A., Ninan B. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Ann. Vasc. Surg. 2009, 23:645-651.
22. Boaz M., Smetana S., Weinstein T., Matas Z., Grater U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M.S. Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000, 356:1213-1218.